The clinical severity of haemophilia is usually related to residual cl
otting factor activity. Reports of factor V deficiency or protein C ha
ve been described in haemophilic patients and both are involved in the
activated protein C pathway. Recently, the poor response to activated
protein C due to factor V Leiden (FQ506) has been associated with an
increased risk of thrombosis and its incidence in the normal populatio
n is given as 2-7%. We describe three cases of severe haemophilia A he
terozygous for factor V Leiden and its influence on phenotype.